Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Hematology | Devices
Disease Category: Hemodialysis
Location: United States, NY

Clinical Trial Details

Overview

Research Study Summary

End-stage Renal Disease Hemodialysis

Purpose

The purpose of this study is to test a new liquid drug (during the dialysis procedure) containing iron that may help maintain your iron storage ability for people who are on chronic hemodialysis for end-stage renal disease.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

  • Be at least 18 years old undergoing chronic hemodialysis for end-stage renal disease three times a week

You will not qualify if you:

  • Are pregnant or breast-feeding
  • Have HIV
  • Have active infections
  • Have participated in a clinical drug or device trial within the last 30 days

To Learn more

CW ID: 134393
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Facility Type
N/A

Contact

Susan Mathew, Research Coordinator
Biomedical Research Alliance of New York
North Shore University Hospital
100 Community Drive - 2nd Floor
Great Neck, NY 11021
Phone: 516-465-8200

View Map

Research Center Information: Biomedical Research Alliance of New York

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.